Ameriprise’s PMV Pharmaceuticals PMVP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $16.4K | Sell |
13,237
-51,877
| -80% | -$66K | ﹤0.01% | 4030 |
|
|
2025
Q4 | $81.4K | Buy |
65,114
+54,174
| +495% | +$72.6K | ﹤0.01% | 4017 |
|
|
2025
Q3 | $15.3K | Buy |
+10,940
| New | +$15.1K | ﹤0.01% | 4044 |
|
|
2025
Q2 | – | Sell |
-18,007
| Closed | -$19.6K | – | 4092 |
|
|
2025
Q1 | $19.6K | Sell |
18,007
-4,800
| -21% | -$6.52K | ﹤0.01% | 3985 |
|
|
2024
Q4 | $34.4K | Sell |
22,807
-16,715
| -42% | -$26.5K | ﹤0.01% | 4030 |
|
|
2024
Q3 | $58.9K | Sell |
39,522
-10,272
| -21% | -$15.9K | ﹤0.01% | 3872 |
|
|
2024
Q2 | $80.7K | Hold |
49,794
| – | – | ﹤0.01% | 3790 |
|
|
2024
Q1 | $84.7K | Sell |
49,794
-75,586
| -60% | -$141K | ﹤0.01% | 3788 |
|
|
2023
Q4 | $389K | Buy |
125,380
+43,195
| +53% | +$114K | ﹤0.01% | 3540 |
|
|
2023
Q3 | $505K | Buy |
82,185
+865
| +1% | +$5.95K | ﹤0.01% | 3412 |
|
|
2023
Q2 | $509K | Sell |
81,320
-285
| -0.3% | -$1.49K | ﹤0.01% | 3430 |
|
|
2023
Q1 | $389K | Buy |
81,605
+1,280
| +2% | +$9.01K | ﹤0.01% | 3519 |
|
|
2022
Q4 | $699K | Sell |
80,325
-5
| -0% | -$53 | ﹤0.01% | 3277 |
|
|
2022
Q3 | $956K | Sell |
80,330
-1,521
| -2% | -$22K | ﹤0.01% | 3133 |
|
|
2022
Q2 | $1.17M | Buy |
81,851
+22,258
| +37% | +$324K | ﹤0.01% | 3053 |
|
|
2022
Q1 | $1.24M | Buy |
59,593
+8,006
| +16% | +$141K | ﹤0.01% | 3118 |
|
|
2021
Q4 | $1.19M | Buy |
51,587
+19,371
| +60% | +$468K | ﹤0.01% | 3182 |
|
|
2021
Q3 | $960K | Sell |
32,216
-2,990
| -8% | -$95.5K | ﹤0.01% | 3181 |
|
|
2021
Q2 | $1.14M | Buy |
35,206
+17,887
| +103% | +$597K | ﹤0.01% | 3169 |
|
|
2021
Q1 | $570K | Buy |
17,319
+13,706
| +379% | +$540K | ﹤0.01% | 3348 |
|
|
2020
Q4 | $222K | Buy |
+3,613
| New | +$142K | ﹤0.01% | 3601 |
|
Other funds holding PMVP
BCM
TCM
SCM
ACH
EC
EP
VCM
